Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Etfmg Treatments Testing and Advancements ETF (GERM)

Etfmg Treatments Testing and Advancements ETF (GERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ETF Managers Group
  • Assets Under Management 76,163,500
  • Market Capitalization, $K 76,164
  • Shares Outstanding, K 2,350
  • 60-Month Beta 0.00
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.68%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.75 +7.56%
on 07/14/20
35.15 -8.96%
on 07/20/20
+2.38 (+8.04%)
since 07/10/20

Most Recent Stories

More News
Another COVID-Themed ETF Digital Health (EDOC) Hits Market

Global X recently announced the launch of the Global X Telemedicine & Digital Health ETF (EDOC), broadening the issuer???s portfolio of thematic ETFs.

WFH : 53.20 (-0.75%)
VIRS : 26.72 (-0.63%)
EDUT : 15.88 (-2.04%)
EDOC : 15.70 (-1.63%)
GERM : 32.00 (-1.39%)
Top ETF Stories of July

Wall Street has been steady in July despite the rise in coronavirus cases due to fiscal and monetary stimulus, coronavirus vaccine hopes, pent-up consumer demand and decent earnings releases.

MRNA : 72.01 (-2.82%)
FXE : 110.67 (-0.39%)
JETS : 17.45 (+4.80%)
XLY : 142.06 (+1.20%)
QCLN : 38.58 (+1.31%)
USV : 36.85 (+1.32%)
GERM : 32.00 (-1.39%)
Top ETF Stories of July

Wall Street has been steady in July despite the rise in coronavirus cases due to fiscal and monetary stimulus, coronavirus vaccine hopes, pent-up consumer demand and decent earnings releases.

MRNA : 72.01 (-2.82%)
FXE : 110.67 (-0.39%)
JETS : 17.45 (+4.80%)
XLY : 142.06 (+1.20%)
QCLN : 38.58 (+1.31%)
USV : 36.85 (+1.32%)
GERM : 32.00 (-1.39%)
Moderna Turns Red Hot: Biotech ETFs to Bet On

Moderna skyrocketed 245% since it announced its COVID-19 vaccine candidate mRNA-1273 on Feb 10. The solid run is likely to continue as most of the analysts are optimistic on the stock.

MRNA : 72.01 (-2.82%)
IBB : 134.87 (-1.00%)
CNCR : 26.31 (+0.46%)
XBI : 113.91 (-0.01%)
BBH : 161.58 (-1.55%)
BTEC : 45.45 (-0.79%)
IDNA : 38.38 (-0.23%)
GERM : 32.00 (-1.39%)
COVID-19 Vaccine Push Brings Hope: Stock & ETF Beneficiaries

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.

AZN : 55.38 (-0.05%)
PFE : 38.39 (-0.16%)
MRNA : 72.01 (-2.82%)
NVAX : 178.51 (+4.83%)
PPH : 63.87 (+0.17%)
PTH : 142.23 (-0.08%)
IPO : 43.66 (-1.84%)
FTXH : 24.50 (+0.16%)
VXRT : 9.40 (+2.29%)
GERM : 32.00 (-1.39%)
Top-Performing ETFs of Last Week

Last week was moderately upbeat for Wall Street with vaccine hopes boosting risk-on sentiments.

TSLA : 1,418.57 (-2.35%)
PKB : 35.55 (+1.40%)
PSCM : 43.84 (+4.46%)
XHS : 78.52 (+0.46%)
MLPC : 7.84 (+2.22%)
MJJ : 55.10 (+0.71%)
GERM : 32.00 (-1.39%)
Top and Flop ETFs to Start Third Quarter

We have highlighted ETFs from the best and worst zones to start the third quarter.

PFE : 38.39 (-0.16%)
MRNA : 72.01 (-2.82%)
VSLR : 25.91 (+2.86%)
TAN : 51.28 (+0.16%)
VXX : 25.75 (-2.94%)
RUN : 47.28 (+2.78%)
KBWR : 37.56 (+1.95%)
MLPO : 6.64 (unch)
DFVL : 76.45 (unch)
GERM : 32.00 (-1.39%)
Should You Invest in Coronavirus Themed ETFs?

Here is what you need to know about the new ETFs that capitalize on Covid-19 themes

NVDA : 446.60 (-0.31%)
AMZN : 3,148.16 (-0.61%)
MRNA : 72.01 (-2.82%)
NFLX : 483.38 (-2.29%)
NVAX : 178.51 (+4.83%)
INO : 18.99 (-6.08%)
VIRS : 26.72 (-0.63%)
GERM : 32.00 (-1.39%)
Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

PFE : 38.39 (-0.16%)
MRNA : 72.01 (-2.82%)
IBB : 134.87 (-1.00%)
CNCR : 26.31 (+0.46%)
XBI : 113.91 (-0.01%)
BBH : 161.58 (-1.55%)
FBT : 164.54 (-1.08%)
BTEC : 45.45 (-0.79%)
IDNA : 38.38 (-0.23%)
GERM : 32.00 (-1.39%)
How to Tap Red-Hot Moderna Stock With ETFs

Moderna shares have surged more than 280% so far this year on the positive development of coronavirus vaccine.

MRNA : 72.01 (-2.82%)
IBB : 134.87 (-1.00%)
CNCR : 26.31 (+0.46%)
XBI : 113.91 (-0.01%)
BBH : 161.58 (-1.55%)
BTEC : 45.45 (-0.79%)
IDNA : 38.38 (-0.23%)
GERM : 32.00 (-1.39%)
Trade GERM with:

Fund Summary

The ETFMG Treatments Testing and Advancements ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

2nd Resistance Point 33.34
1st Resistance Point 32.67
Last Price 32.00
1st Support Level 31.57
2nd Support Level 31.14

See More

52-Week High 35.15
Last Price 32.00
Fibonacci 61.8% 31.33
Fibonacci 50% 30.15
Fibonacci 38.2% 28.97
52-Week Low 25.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar